The role of tumor microenvironment in prostate cancer bone metastasis
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Prostate cancer (PCa) epithelial cells require a number of factors to facilitate their establishment and growth at a distant site of metastasis. Their ability to adapt to their microenvironment, proliferate and recruit an underlying stroma is integral to the survival and growth of the metastasis. PCa predominantly metastasizes to the bone, and bone metastases are the main cause of morbidity. The bone marrow provides a permissive environment for the formation of a metastasis. In some cases, the cells may remain dormant for some time, eventually proliferating in response to an unknown “trigger.” The marrow is rich in progenitor cells that differentiate into numerous cell types, producing new blood vessels, supporting fibroblasts, and an underlying extracellular matrix (ECM) that form the reactive stroma. By secreting a number of cytokines, growth factors and proteases they recruit auxiliary cells required to produce a functional stroma. These components are involved in a reciprocal interaction between the stroma and the PCa cells, allowing for the growth and survival of the tumor. Left unchecked, once a PCa tumor has established itself in the bone marrow it will eventually replace the marrow, interrupting bone homeostasis and typically promoting an osteoblastic response in the bone including osteoclastic events. The abundant deposition of new woven bone results in nerve compression, bone pain and an increase in fractures in patients with PCa bone metastases. This review will examine the tumor microenvironment, its role in facilitating tumor dissemination, growth and the resultant pathologies associated with PCa bone metastasis. J. Cell. Biochem. 101: 873–886, 2007. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients
Bubendorf, L., Schöpfer, A., Wagner, U., Sauter, G., Moch, H., Willi, N., Gasser, T. C., & Mihatsch, M. J. (2000) · Human Pathology · doi:10.1053/hp.2000.6698 · Cited by 1,895 · cited 1×
“PCa metastasizes to the bone with skeletal involvement in approximately 90% of patients with advanced PCa [Bubendorf et al., 2000; Roudier et al., 2004].”
BackgroundOpenings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
Cancer cells compress intratumour vessels
Padera, T. P., Stoll, B. R., Tooredman, J. B., Capen, D., Tomaso, E. D., & Jain, R. K. (2004) · Nature · doi:10.1038/427695a · Cited by 857 · cited 1×
“CD31, CD171, and developmental endothelial locus-1 (Del-1) adhesion molecules are known to be ligands of avb3 and avb5 as well as components of the ECM [Penta et al., 1999; Voura et al., 2001; Aoka et al., 2002].”
BackgroundZhang, J., Dai, J., Qi, Y., Lin, D.-L., Smith, P., Strayhorn, C., Mizokami, A., Fu, Z., Westman, J., & Keller, E. T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11685 · Cited by 452 · cited 14×
“Results of preclinical studies have also shown that inhibition of RANK/RANKL signaling decreases tumor growth and/or establishment and prevented osteolysis in PCa [Zhang et al., 2001] in the bone environment.”
BackgroundInfluentialOsteoprotegerin and RANK ligand expression in prostate cancer.
Brown, J. M., Corey, E., Lee, Z. D., True, L. D., Yun, T. J., Tondravi, M., & Vessella, R. L. (2001) · Urology · doi:10.1016/s0090-4295(00)01122-5 · Cited by 234 · cited 14×
“Results of preclinical studies have also shown that inhibition of RANK/RANKL signaling decreases tumor growth and/or establishment and prevented osteolysis in PCa [Zhang et al., 2001] in the bone environment.”
BackgroundSelf-citationBERRUTI, A., DOGLIOTTI, L., BITOSSI, R., FASOLIS, G., GORZEGNO, G., BELLINA, M., TORTA, M., PORPIGLIA, F., FONTANA, D., & ANGELI, A. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67149-2 · Cited by 212 · cited 1×
“Increased bone resorption is also a prognostic factor for skeletal-related events in metastatic PCa [Berruti et al., 2000].”
BackgroundDel1 Induces Integrin Signaling and Angiogenesis by Ligation of αVβ3
Penta, K., Varner, J. A., Liaw, L., Hidai, C., Schatzman, R., & Quertermous, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.11101 · Cited by 153 · cited 1×
“CD31, CD171, and developmental endothelial locus-1 (Del-1) adhesion molecules are known to be ligands of avb3 and avb5 as well as components of the ECM [Penta et al., 1999; Voura et al., 2001; Aoka et al., 2002].”
BackgroundMichaelson, M. D., Marujo, R. M., & Smith, M. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0735 · Cited by 60
Cited by
Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks
Liu, S., Ginestier, C., Ou, S. J., Clouthier, S. G., Patel, S. H., Monville, F., Korkaya, H., Heath, A., Dutcher, J., Kleer, C. G., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-0538 · Cited by 611
Bragado, P., Estrada, Y., Parikh, F., Krause, S., Capobianco, C., Farina, H. G., Schewe, D. M., & Aguirre-Ghiso, J. A. (2013) · Nature Cell Biology · doi:10.1038/ncb2861 · Cited by 503
Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow
Yumoto, K., Eber, M. R., Wang, J., Cackowski, F. C., Decker, A. M., Lee, E., Nobre, A. R., Aguirre-Ghiso, J. A., Jung, Y., & Taichman, R. S. (2016) · Scientific Reports · doi:10.1038/srep36520 · Cited by 170
Metadata
- Authors
- Morrissey, C., & Vessella, R. L.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2007-03-23
- Volume
- 101
- Issue
- 4
- Pages
- 873-886
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2027525928
- Cited by
- 109
- References
- 8
- FWCI
- 10.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of tumor microenvironment in prostate cancer bone metastasis. https://app.cochat.ai/papers/10.1002/jcb.21214
- The paper
- Morrissey, C., & Vessella, R. L. (2007). The role of tumor microenvironment in prostate cancer bone metastasis. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.21214
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.